BONNasdaqMedicinal Chemicals & Botanical ProductsFiscal year ends September 30

Bon Natural Life Ltd

Financials through fiscal 2025, year ended Sep 30, 2025Last filing: 20-F on Jan 23, 2026

$1.12−0.02 (-1.51%)

Close on Oct 19, 2026

Market cap: –
P/E (TTM): –
Dividend yield: –

Bon Natural Life Ltd income statement

AnnualQuarterlyTTM

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-09-30	FY 2024 2024-09-30	FY 2023 2023-09-30	FY 2022 2022-09-30	FY 2021 2021-09-30	FY 2020 2020-09-30	FY 2019 2019-09-30
Revenue	19	24	30	30	25	18	16
Cost of Revenue	15	17	21	20	18	13	11
Gross Profit	3.88	7.11	8.84	9.42	7.11	5.20	5.28
Research & Development	0.75	1.62	0.30	0.42	0.25	0.21	0.52
General & Administrative	4.31	3.35	2.31	2.18	1.32	1.37	1.31
Advertising Expenses	–	–	–	–	0.03	0.01	0.05
Operating Expenses	5.50	5.24	2.90	2.82	1.71	1.73	2.11
Operating Income	-1.62	1.87	5.94	6.60	5.40	3.47	3.18
Interest Expense	0.37	0.30	0.24	0.45	0.42	0.33	0.33
Interest & Investment Income	0.00	0.00	0.01	0.00	0.00	0.00	0.00
Other Non-Operating Income	-0.09	-1.16	-0.36	0.97	0.03	0.19	-0.19
Gain (Loss) on Sale of Assets	–	–	–	0.00	–	0.02	–
Pretax Income	-1.71	0.72	5.57	7.57	5.43	3.65	2.99
Income Tax Expense	0.34	0.35	1.00	1.27	0.82	0.56	0.43
Income from Continuing Operations	-2.05	0.36	4.57	6.30	–	–	–
Income from Discontinued Operations	–	-0.02	-0.02	-0.06	–	–	–
Net Income incl. Noncontrolling Interests	-2.05	0.35	4.55	6.24	4.61	3.10	2.56
Minority Interest in Earnings	-0.05	-0.05	-0.04	0.00	0.02	0.07	-0.01
Net Income	-1.99	0.40	4.60	6.24	4.59	3.03	2.57
EPS (Basic)(per share)	-0.72	4.17	125.72	7.47	0.69	0.58	0.50
EPS (Diluted)(per share)	-0.72	4.14	124.92	7.43	0.68	0.58	0.50
Shares Outstanding (Basic, Weighted)(shares)	2.76	0.10	0.04	0.84	6.62	5.21	5.17
Shares Outstanding (Diluted, Weighted)(shares)	2.76	0.10	0.04	0.84	6.71	5.21	5.17
EBITDA	-0.54	2.98	6.89	6.82	5.63	3.70	3.40

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Sep 30, 2025

Profitability, FY2025

Gross margin: 20.8%
Operating margin: -8.7%
Net margin: -10.7%
Return on equity, FY2025: -3.9%

Financial strength

Current ratio: 1.74
Debt to equity: 0.21
Debt to assets: 14.3%
Cash to current liabilities: 14.3%

Valuation

P/E ratio: –
Price to sales: –
Price to book: –
Dividend yield: –